Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer

Published:2023-04 Issue: Volume:Volume 17 Page:1049-1062
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Engel-Nitz Nicole M^ORCID,Johnson Mary G^ORCID,Johnson Michael P^ORCID,Cha-Silva Ashley S^ORCID,Kurosky Samantha K,Liu Xianchen^ORCID

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference34 articles.

1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer v8.2021; 2021. Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast_blocks.pdf. Accessed November 11, 2021.

2. Goals of Treatment for Patients With Metastatic Breast Cancer

3. Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis

4. Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study

5. Palbociclib and Letrozole in Advanced Breast Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palbociclib in Older Patients with Advanced/Metastatic Breast Cancer: A Systematic Review;Targeted Oncology;2024-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP